[{"address1": "12770 High Bluff Drive", "address2": "Suite 150", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "619 949 3681", "website": "https://www.gyretx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY, under Phase 3 trials for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis; and completed Phase 1 trials for the treatment of liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. In addition, the company develops F573 is in Phase 2 clinical trials for the treatment of acute/acute-on-chronic liver failure. Further, its preclinical products include F230 for the treatment of pulmonary arterial hypertension; and F528 to treat chronic obstructive pulmonary disease. The company was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.", "fullTimeEmployees": 579, "companyOfficers": [], "auditRisk": 7, "boardRisk": 10, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 9, "governanceEpochDate": 1754006400, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.22, "open": 8.29, "dayLow": 8.0, "dayHigh": 8.29, "regularMarketPreviousClose": 8.22, "regularMarketOpen": 8.29, "regularMarketDayLow": 8.0, "regularMarketDayHigh": 8.29, "payoutRatio": 0.0, "trailingPE": 407.00003, "forwardPE": 17.695652, "volume": 60337, "regularMarketVolume": 60337, "averageVolume": 217179, "averageVolume10days": 82250, "averageDailyVolume10Day": 82250, "bid": 8.05, "ask": 8.2, "bidSize": 1, "askSize": 1, "marketCap": 739330176, "fiftyTwoWeekLow": 6.11, "fiftyTwoWeekHigh": 19.0, "priceToSalesTrailing12Months": 7.234929, "fiftyDayAverage": 7.652, "twoHundredDayAverage": 10.0597, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 723742848, "profitMargins": 0.040760003, "floatShares": 20455117, "sharesOutstanding": 90826800, "sharesShort": 1852217, "sharesShortPriorMonth": 1804234, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.020399999, "heldPercentInsiders": 0.87162, "heldPercentInstitutions": 0.03754, "shortRatio": 19.51, "shortPercentOfFloat": 0.123100005, "impliedSharesOutstanding": 90826800, "bookValue": 1.013, "priceToBook": 8.035539, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "earningsQuarterlyGrowth": -0.875, "netIncomeToCommon": 4165000, "trailingEps": 0.02, "forwardEps": 0.46, "lastSplitFactor": "1:15", "lastSplitDate": 1698710400, "enterpriseToRevenue": 7.082, "enterpriseToEbitda": 63.788, "52WeekChange": -0.30782312, "SandP52WeekChange": 0.15005577, "lastDividendValue": 3.6, "lastDividendDate": 1673568000, "quoteType": "EQUITY", "currentPrice": 8.14, "targetHighPrice": 20.0, "targetLowPrice": 20.0, "targetMeanPrice": 20.0, "targetMedianPrice": 20.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 54365000, "totalCashPerShare": 0.599, "ebitda": 11346000, "totalDebt": 1393000, "quickRatio": 4.682, "currentRatio": 5.395, "totalRevenue": 102189000, "debtToEquity": 1.076, "revenuePerShare": 1.181, "returnOnAssets": 0.042680003, "returnOnEquity": 0.07842, "grossProfits": 98009000, "earningsGrowth": -0.27, "revenueGrowth": 0.061, "grossMargins": 0.9591, "ebitdaMargins": 0.11103, "operatingMargins": 0.08113, "financialCurrency": "USD", "symbol": "GYRE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Gyre Therapeutics, Inc.", "shortName": "Gyre Therapeutics, Inc.", "averageDailyVolume3Month": 217179, "fiftyTwoWeekLowChange": 2.0300002, "fiftyTwoWeekLowChangePercent": 0.33224225, "fiftyTwoWeekRange": "6.11 - 19.0", "fiftyTwoWeekHighChange": -10.86, "fiftyTwoWeekHighChangePercent": -0.5715789, "fiftyTwoWeekChangePercent": -30.782312, "dividendDate": 1673481600, "earningsTimestampStart": 1762804800, "earningsTimestampEnd": 1762804800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 0.02, "epsForward": 0.46, "fiftyDayAverageChange": 0.4880004, "fiftyDayAverageChangePercent": 0.06377423, "twoHundredDayAverageChange": -1.9196997, "twoHundredDayAverageChangePercent": -0.19083071, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "marketState": "CLOSED", "regularMarketChangePercent": -0.973235, "regularMarketPrice": 8.14, "corporateActions": [], "postMarketTime": 1755288244, "regularMarketTime": 1755288002, "exchange": "NCM", "messageBoardId": "finmb_100542295", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1144848600000, "postMarketChangePercent": 0.0, "postMarketPrice": 8.14, "postMarketChange": 0.0, "regularMarketChange": -0.0799999, "regularMarketDayRange": "8.0 - 8.29", "fullExchangeName": "NasdaqCM", "displayName": "Gyre Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]